Davie, A., S. Traoré, M. Giovannitti, G. Pompilio, M. Lambton, E. Cakar, and A. Chatterjee. “Cost-Effectiveness Analysis of Abemaciclib With Endocrine Therapy (ET) Versus ET Alone for HR+, HER2−, Node-Positive, High-Risk Early Breast Cancer in Italy”. Global and Regional Health Technology Assessment, vol. 10, no. 1, Sept. 2023, pp. 62-69, doi:10.33393/grhta.2023.2561.